前瞻性临床实验肝癌病患肿瘤切除後由肝门脉辅助性化学药物灌注ppt课件.pptVIP

Hepatic Resection for BCLC Stage B and C HCC;Outline;Barcelona Clinic Liver Cancer (BCLC) Staging;Treatment Option for HCC;;Concept of “ideal” candidates for resection in BCLC guidelines 5 years survival 50% Operative mortality 3% Transfusion rate 10% Comparative survival with non-surgical treatment was not described as a consideration ;;;Hepatic Resection as the First-line Treatment for BCLC B/C Patients: Pros and Cons;;Mortality Following Resection or TACE for HCC Patients (Taipei VGH);BCLC B/C HCC: Treatment-related Mortality;;Anatomical Resection of HCC: Offer a Chance for a Cure;;Recently, an increasing number of studies have focused on the indication of hepatic resection in HCC patients with BCLC stages B and C. Whether liver resection can yield better survival outcomes in BCLC B HCC? Is there a role for liver resection in patients with BCLC C HCC? ;Chang WT, et al. Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection? Surgery 2012;152:809. Hsu CY, et al. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study. Ann Surg Oncol 2015 Oct 20 Liu PH, et al. Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. J Surg Oncol 2015;111:404 Liu PH, et al. Surgical resection is better than transarterial chemoembolization for hepatocellular carcinoma beyond Milan criteria independent of performance status. J Gastrointest Surg 2014;18:1623. Liu PH, et al. Surgical resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis. Ann Surg Oncol 2014;21:1825.;3 recently published articles on HCC 1) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: Is it adherent to the EASL